-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
BeyondSpring (NASDAQ:BYSI) Shares Up 0.7%
BeyondSpring (NASDAQ:BYSI) Shares Up 0.7%
BeyondSpring Inc. (NASDAQ:BYSI – Get Rating)'s share price shot up 0.7% during trading on Monday . The stock traded as high as $1.57 and last traded at $1.52. 165,615 shares traded hands during trading, a decline of 59% from the average session volume of 403,071 shares. The stock had previously closed at $1.51.
BeyondSpring Stock Performance
The company has a market capitalization of $57.23 million, a PE ratio of -0.88 and a beta of 1.04. The firm has a fifty day moving average of $1.52 and a two-hundred day moving average of $1.94.
Get BeyondSpring alerts:Institutional Investors Weigh In On BeyondSpring
Several institutional investors have recently bought and sold shares of BYSI. Walleye Capital LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $28,000. Mirabella Financial Services LLP purchased a new stake in BeyondSpring during the 1st quarter valued at about $44,000. Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring during the 2nd quarter valued at about $44,000. Fox Run Management L.L.C. purchased a new stake in BeyondSpring during the 4th quarter valued at about $56,000. Finally, Acadian Asset Management LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $76,000. 18.89% of the stock is currently owned by hedge funds and other institutional investors.
About BeyondSpring
(Get Rating)BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
Featured Stories
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- Workhorse Group Is Ready To Get Back On The Horse
- Are 3M, Honeywell, GE Buys After Quarterly Reports?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
BeyondSpring Inc. (NASDAQ:BYSI – Get Rating)'s share price shot up 0.7% during trading on Monday . The stock traded as high as $1.57 and last traded at $1.52. 165,615 shares traded hands during trading, a decline of 59% from the average session volume of 403,071 shares. The stock had previously closed at $1.51.
納斯達克週一盤中股價飆升0.7%,盤中一度漲至1.57美元,最新報1.52美元。當日有165,615股股票易手,較403,071股的日均成交量下跌59%。此前該股收盤價為1.51美元。
BeyondSpring Stock Performance
萬春醫藥股票表現
The company has a market capitalization of $57.23 million, a PE ratio of -0.88 and a beta of 1.04. The firm has a fifty day moving average of $1.52 and a two-hundred day moving average of $1.94.
該公司市值為5723萬美元,市盈率為-0.88,貝塔係數為1.04。該公司的50日移動均線切入位在1.52美元,200日移動均線切入位在1.94美元。
Institutional Investors Weigh In On BeyondSpring
機構投資者在萬春醫藥上發表看法
Several institutional investors have recently bought and sold shares of BYSI. Walleye Capital LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $28,000. Mirabella Financial Services LLP purchased a new stake in BeyondSpring during the 1st quarter valued at about $44,000. Orion Portfolio Solutions LLC purchased a new stake in BeyondSpring during the 2nd quarter valued at about $44,000. Fox Run Management L.L.C. purchased a new stake in BeyondSpring during the 4th quarter valued at about $56,000. Finally, Acadian Asset Management LLC purchased a new stake in BeyondSpring during the 1st quarter valued at about $76,000. 18.89% of the stock is currently owned by hedge funds and other institutional investors.
幾家機構投資者最近買賣了比亞迪的股票。Walleye Capital LLC在第一季度購買了萬春醫藥的新股份,價值約28,000美元。米拉貝拉金融服務有限責任公司在第一季度購買了萬春醫藥的新股份,價值約44,000美元。獵户座投資組合解決方案有限責任公司在第二季度購買了萬春醫藥的新股份,價值約44,000美元。狐狸奔跑管理有限公司在第四季度購買了萬春醫藥的新股份,價值約56,000美元。最後,阿卡迪亞資產管理有限責任公司在第一季度購買了萬春醫藥的新股份,價值約76,000美元。18.89%的股票目前由對衝基金和其他機構投資者持有。
About BeyondSpring
關於萬春醫藥
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.
萬春醫藥是一家臨牀期生物製藥公司,與其子公司一起專注於癌症療法的開發。該公司的主要資產是普利布林,這是一種選擇性免疫調節微管結合劑,已經完成了預防化療引起的中性粒細胞減少症和治療晚期非小細胞肺癌的第三階段臨牀試驗。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on BeyondSpring (BYSI)
- The How And Why of Investing in Oil Stocks
- The How and Why of Investing in Gold Stocks
- A Rounded Bottom In Draftkings, Inc Begins To Reverse Course
- Workhorse Group Is Ready To Get Back On The Horse
- Are 3M, Honeywell, GE Buys After Quarterly Reports?
- 在新浪萬春醫藥上免費獲取斯托克新聞網的研究報告
- 投資石油股票的方式和原因
- 投資黃金股票的方式和原因
- DraftKings,Inc.的圓底開始逆轉
- 工作馬集團準備重返賽馬
- 3M、霍尼韋爾、通用電氣在季度報告後收購嗎?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
接受萬春醫藥日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對萬春醫藥及相關公司評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧